Scinovex
review Open AccessTop 1% cited

The SARS-CoV-2 main protease as drug target

Bioorganic & Medicinal Chemistry Letters · 2020 · Vol. 30(17) · pp. 127377–127377
Sven UllrichChristoph Nitsche
SARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsCOVID-19 Clinical Research StudiesProteasesProteaseDrug discoveryPeptidomimeticVirologyCoronavirusDrugChemistrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug development

MeSH terms

BetacoronavirusSARS-CoV-2Coronavirus 3C ProteasesAmino Acid SequenceAnimalsAntiviral AgentsCell LineCysteine EndopeptidasesHumansSubstrate SpecificityCysteine Proteinase InhibitorsViral Nonstructural ProteinsDrug DiscoveryPeptidomimetics

Funding

  • Australian Research Council
Citations
785
FWCI
15.74
field-weighted impact
References
114
Percentile
99%
vs. same field & year
Citations per year
References
On the size of the active site in proteases. I. Papain
Biochemical and Biophysical Research Communications · 1967 · 5,205 citations
Virus-encoded proteinases and proteolytic processing in the Nidovirales
Journal of General Virology · 2000 · 1,056 citations
UCSF Chimera—A visualization system for exploratory research and analysis
Journal of Computational Chemistry · 2004 · 47,120 citations
WebLogo: A Sequence Logo Generator: Figure 1
Genome Research · 2004 · 12,864 citations
Mechanisms and enzymes involved in SARS coronavirus genome expression
Journal of General Virology · 2003 · 885 citations
Origin and evolution of pathogenic coronaviruses
Nature Reviews Microbiology · 2018 · 5,807 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.